European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Defossilization of pharmaceutical manufacturing.

Compounding

Quality Matters

AUGUST 3, 2023

They comprise interconnected webs of local and global ingredient suppliers, manufacturers, packagers, distributors, providers, and regulators. active ingredients, excipients, other raw materials) Packaging materials (e.g., Global supply chains are complex and vulnerable to disruption.

Packaging

Pharmaceutical Technology

MAY 11, 2008

Data has long been incorporated into drug packaging to accomplish these goals, but only to a partial degree with embossed lot numbers, expiry dates and even Braille identification in addition to linear bar codes. For example, Turkey will require track and trace by 1 January 2009 and California is requiring the technology by 1 January 2011.

Packaging

GMPSOP

OCTOBER 28, 2023

Packaging material specifications In the pharmaceutical industry, the requirements for pre-printed packaging materials must be well-defined and documented to ensure that you get the items you specified or ordered and that there are no mix-ups. A standard name and a unique item code define packaging materials.

Documentation

GMPSOP

MAY 31, 2024

The validation plan applies to all existing and new drug compounds and registered drug products or active pharmaceutical ingredients (APIs) for clinical use or sale. The validation master plan in the pharmaceutical industry must provide evidence that the following major changes comply with regulatory expectations.

Documentation

GMPSOP

FEBRUARY 28, 2024

Sometimes, pharmaceutical manufacturers employ surface profilometry to assess the roughness of stainless-steel equipment. In other areas, such as secondary packaging or material storage areas, the product isn’t directly exposed to the environment, so there is a lower risk of contamination. if used on pre-cleaned surfaces.

Documentation

Express Pharma

JUNE 5, 2024

Although less commonly discussed, pharmaceutical compounds can also become airborne. This can occur through the evaporation of volatile substances or the incineration of pharmaceutical waste, potentially affecting air quality and contributing to broader environmental pollution.

Pharmaceutical Manufacturing

GMPSOP

MAY 17, 2024

Sometimes, pharmaceutical manufacturers employ surface profilometry to assess the roughness of stainless-steel equipment. In other areas, such as secondary packaging or material storage areas, the product isn’t directly exposed to the environment, so there is a lower risk of contamination. Protease, amylase, or lipase enzymes).

Documentation

PharmaTech

JULY 22, 2025

Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. Image Credit: © wacomka - stock.adobe.com PMMI, The Association for Packaging and Processing Technologies, has announced some of the unique features being made available to attendees at Pack Expo Las Vegas, to be held from Sept.

Dosage

GMPSOP

JULY 14, 2023

In this article, we will discuss important aspects of equipment cleaning that are required during pharmaceutical manufacturing. In other areas, such as in secondary packaging or in material storage areas, the product isn’t exposed to the environment, so there is a lower risk of contamination.

Documentation

GMPSOP

JULY 31, 2023

Pharmaceutical manufacturing operations typically maintain equipment varying from simple balances and scales to complex automated process control and monitoring systems. – Gas Chromatography (GC) Systems (Critical for analyzing volatile compounds). When is equipment qualification necessary?

Documentation

Quality Matters

OCTOBER 13, 2021

In addition to standards for active pharmaceutical ingredients, USP also develops standards for the inactive ingredients (excipients) and other raw materials used in drug manufacturing. In a 2019 report on drug shortages, the FDA found that 62% of drug shortages occur because of quality issues in manufacturing.

Pharmaceutical Manufacturing